Kura Oncology Inc (KURA) — Capital Reinvestment Ratio

Latest as of December 2025: 0.02x

Kura Oncology Inc (KURA) has a Capital Reinvestment Ratio of 0.02x as of December 2025, meaning it reinvests 0% of its operating cash flow ($117.27 Million) in capital expenditures ($2.32 Million). Check tangible equity quality of Kura Oncology Inc to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.02x

Capex / Operating Cash Flow

Operating Cash Flow

$117.27 Million

USD

Capital Expenditures

$2.32 Million

USD

Data as of

Dec 2025

Most recent filing

Kura Oncology Inc Capital Reinvestment Ratio (2024–2024)

This chart tracks Kura Oncology Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see Kura Oncology Inc (KURA) cash conversion ratio.

Annual Capital Reinvestment Ratio for Kura Oncology Inc (2024–2024)

Year-by-year Capital Reinvestment Ratio for Kura Oncology Inc from 2024 to 2024. See KURA free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change
2024	0.00x	$134.32 Million	$472.00K	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow